Questionnaire for the Assessment of Symptoms and Psychological Effects in Cardiovascular Therapy (the ASPECT Scale)
Overview
Authors
Affiliations
This brief review summarizes the background and principles for the development of a new psychometric instrument (Assessment of Symptoms and Psychological Effects in Cardiovascular Therapy--ASPECT Scale). The test consists of two parts, one for assessment of three aspects of global well-being (hedonic tone, relaxation, and activity) and one for evaluation of 34 commonly experienced symptomatic side-effects of cardiovascular drugs. All items are assessed by visual-analogue scales, and six clusters of symptoms have been identified: cardiac symptoms, central nervous system or cognitive symptoms, fatigue, local/cutaneous symptoms, sleeping disturbances, and other symptoms.
Brown D, Boston R, Coyne J, Farrar J Am J Vet Res. 2007; 68(6):631-7.
PMID: 17542696 PMC: 2907349. DOI: 10.2460/ajvr.68.6.631.
Wilde M, Bryson H, Goa K Pharmacoeconomics. 1994; 6(2):155-82.
PMID: 10147441 DOI: 10.2165/00019053-199406020-00008.
Impacts of components of the metabolic syndrome on health status and survival in an aged population.
Lindberg O, Tilvis R, Strandberg T, Valvanne J, Sairanen S, Ehnholm C Eur J Epidemiol. 1997; 13(4):429-34.
PMID: 9258549 DOI: 10.1023/a:1007325609315.
Thulin T, Almkvist H, Berglund L, Bjornsson T, Fagher B, Henningsen N Cardiovasc Drugs Ther. 1994; 8(6):845-9.
PMID: 7742263 DOI: 10.1007/BF00877403.
The effects of ACE inhibitors on cognitive function.
OBrien A, Bulpitt C Drugs Aging. 1995; 6(3):173-80.
PMID: 7620231 DOI: 10.2165/00002512-199506030-00001.